A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Generation of First Heart Field-like Cardiac Progenitors and Ventricular-like Cardiomyocytes from Human Pluripotent Stem Cells

6.8K views

⸱

DOI:

10.3791/57688

⸱

June 19th, 2018

 ,  , 

* These authors contributed equally

In This Article

Summary

Here we describe a scalable method, using a simple combination of Activin A and lentivirus-mediated Id1-overexpression, to generate first heart field-like cardiac progenitors and ventricular-like cardiomyocytes from human pluripotent stem cells.

Abstract

The generation of large amounts of functional human pluripotent stem cells-derived cardiac progenitors and cardiomyocytes of defined heart field origin is a pre-requisite for cell-based cardiac therapies and disease modeling. We have recently shown that Id genes are both necessary and sufficient to specify first heart field progenitors during vertebrate development. This differentiation protocol leverages these findings and uses Id1 overexpression in combination with Activin A as potent specifying cues to produce first heart field-like (FHF-L) progenitors. Importantly, resulting progenitors efficiently differentiate (~70–90%) into ventricular-like cardiomyocytes. Here we describe a detailed method to 1) generate Id1-overexpressing hPSCs and 2) differentiate scalable quantities of cryopreservable FHF-L progenitors and ventricular-like cardiomyocytes.

Introduction

Large scale production of human pluripotent stem cells (hPSCs)-derived cardiac progenitors and cardiomyocytes is a pre-requisite for stem cell-based therapies1, disease modeling2,3 and the rapid characterization of novel pathways regulating cardiac differentiation4,5,6 and physiology7,8. Although a number of studies9,10,11,

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Id1 Virus Preparation and Infection

  1. Generate Id1 overexpressing lentivirus by co-transfecting pCMVDR8.74, pMD2.G, and pCDH-EF1-Id1-PGK-PuroR (Addgene: plasmid #107735) into HEK293T cells. Collect viral particles, filtrate, purify from the supernatant, and store at -80 °C as in Kitamura et al. (2003)19. Alternatively, produce Id1 lentivirus commercially by sending pCDH-EF1-Id1-PGK-PuroR to a lentivirus-producing vendor.
    Caution: Please follow lentiviral safety regulations and standard operation protocols.
    Note: IMPORTANT: Optimal virus titer should be at least 108 to 109 Transducin....

Access restricted. Please log in or start a trial to view this content.

Results

Generation of hPSCsId1lines
hPSCs are infected with a lentivirus mediating Id1 overexpression (Figure 1A). Once hPSCId1 are generated, transgene expression is quantified by qRT-PCR (Figure 1B). Only hPSCId1 lines expressing Id1 mRNA at levels greater than 0.005 fold of that of GAPDH should be.......

Access restricted. Please log in or start a trial to view this content.

Discussion

For successful differentiations, make sure to closely follow instructions listed above. In addition, here we highlight key parameters that strongly influence differentiation outcomes. Before starting a differentiation, the following three morphological parameters should be observed: a stem morphology of hPSCsId1, a high cellular compaction and a high confluence (>90%) of the culture at day 0. In that regard, optimal differentiation conditions are best created by plating dissociated hPSCsId1 as s.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

We thank members of the Colas lab for helpful discussions and critical reviews of the manuscript. This study was supported by NIH/NIEHS R44ES023521-02 and CIRM DISC2-10110 grants to Dr. Colas.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
ACTC1 antibodySigmaA7811
Activin AStem Cell TechnologiesHu Recom Activin A
Antibiotic Antimycotic (Anti-Anti)Thermo Fisher Scientific15240062
B27 supplementThermo Fisher Scientific17504044
B27 supplement w/o - insulinThermo Fisher ScientificA1895601
B27 supplement w/o - vitamin AThermo Fisher Scientific12587001
CDH5 antibodyR&D SystemsAF938
CryoStor CS10Stem Cell Technologies7930Cryopreservation reagent
DMEM high GlucoseMediatech10-013-CV 
DPBS w/ Ca & MgCorning21-030-CV
EDTAThermo Fisher Scientific15575-038
FBSVWR89510-186
FluoVolt membrane potential kit  Thermo Fisher ScientificF10488For optical action potential acquisition, please refer to McKeithan et al. 2017
KnockOut Serum ReplacementGibco10828010
Matrigel, Growth Factor ReducedCorning356231Coating reagent
mTeSR1 media kitStem Cell Technologies5850
PBS w/o Ca & MgCorning21-040-CV
Penicillin-StreptomycinGibco
Puromycin Acros227422500
ReLeSRStem Cell Technologies5872Enzyme-free dissociation reagent
RPMI 1640Thermo Fisher Scientific11875-093
TAGLN antibodyAbcamab14106
ThiazovivinStem Cell Technologies72254RHO/ROCK pathway inhibitor
TrypLE ExpressThermo Fisher Scientific12605 -0101X enzyme-containing dissociation reagent
Tyrodes solution mix packets  SigmaT2145-10X1L(For optical action potential acquisition, please refer to McKeithan et al. 2017)

References

  1. Chong, J. J., et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature. 510, 273-277 (2014).
  2. Kodo, K., et al. iPSC-derived cardiomyocytes reveal abnormal TGF-....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

First Heart Field ProgenitorsId1 OverexpressionActivin A DifferentiationLentiviral InfectionCryopreservation ProtocolCardiac DifferentiationVentricular MarkersAction Potential Analysis